Vall d'Hebron Institute of Research (VHIR), profile picture

Vall d'Hebron Institute of Research (VHIR)

85 Slideshow
Sort by
Human Cell Line Authentication. Why is it so important?
vonVall d'Hebron Institute of Research (VHIR)
 
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos que pueden modificarlo" Dr. Miguel Ángel Marín Gabriel
vonVall d'Hebron Institute of Research (VHIR)
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a la pobreza" Dr. Sergio Sosa-Estani
vonVall d'Hebron Institute of Research (VHIR)
 
Using and combining the different tools for predicting the pathogenicity of sequence variants
vonVall d'Hebron Institute of Research (VHIR)
 
Interpretation of sequence variants in the biomedical environment: what should we take into account
vonVall d'Hebron Institute of Research (VHIR)
 
Variant calling and how to prioritize somatic mutations and inheritated variants in NGS data: an advanced overview
vonVall d'Hebron Institute of Research (VHIR)
 
Data analysis pipelines for NGS applications
vonVall d'Hebron Institute of Research (VHIR)
 
NGS and the molecular basis of disease: a practical view
vonVall d'Hebron Institute of Research (VHIR)
 
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
vonVall d'Hebron Institute of Research (VHIR)
 
"Rare diseases as platform to develop novel therapeutic strategies: the example of Fanconi anemia" by Prof. Jordi Surrallés Calonge
vonVall d'Hebron Institute of Research (VHIR)
 
Richard horton, barcelona 2014
vonVall d'Hebron Institute of Research (VHIR)
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by Prof. Milan Macek, M.D, D.Sc.
vonVall d'Hebron Institute of Research (VHIR)
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Influencia del espectro de mutantes y fitnessreplicativo
vonVall d'Hebron Institute of Research (VHIR)
 
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
vonVall d'Hebron Institute of Research (VHIR)
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep Torrent
vonVall d'Hebron Institute of Research (VHIR)